Insider Activity
Boxer Capital, LLC, who already control 10% of shares at Mirati Therapeutics (MRTX), bought 50,000 additional shares of the company's common stock on Jan 10. At $97.50 per share, Boxer Capital paid a total of $4,875,000 for the new shares.